Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;40:491-497
Published online before print August 19, 2002, doi: 10.1161/01.HYP.0000031800.83899.EC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/4/491    most recent
01.HYP.0000031800.83899.ECv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lameris, T. W.
Right arrow Articles by van den Meiracker, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lameris, T. W.
Right arrow Articles by van den Meiracker, A. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Autonomic, reflex, and neurohumoral control of circulation

(Hypertension. 2002;40:491.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Exogenous Angiotensin II Does Not Facilitate Norepinephrine Release in the Heart

Thomas W. Lameris; Sandra de Zeeuw; Dirk J. Duncker; Gooitzen Alberts; Frans Boomsma; Pieter D. Verdouw; Anton H. van den Meiracker

From the Department of Internal Medicine (T.W.L., G.A., F.B., A.H.v.d.M.) and Experimental Cardiology, Thoraxcenter (S.d.Z., K.J.D., P.D.V.), Erasmus MC, Rotterdam, The Netherlands.

Correspondence to Thomas W. Lameris, Dept. Internal Medicine I, Room L 264, University Hospital Dijkzigt, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. E-mail Lameris{at}twl.myweb.nl

Studies on the effect of angiotensin II on norepinephrine release from sympathetic nerve terminals through stimulation of presynaptic angiotensin II type 1 receptors are equivocal. Furthermore, evidence that angiotensin II activates the cardiac sympathetic nervous system in vivo is scarce or indirect. In the intact porcine heart, we investigated whether angiotensin II increases norepinephrine concentrations in the myocardial interstitial fluid (NEMIF) under basal conditions and during sympathetic activation and whether it enhances exocytotic and nonexocytotic ischemia-induced norepinephrine release. In 27 anesthetized pigs, NEMIF was measured in the left ventricular myocardium using the microdialysis technique. Local infusion of angiotensin II into the left anterior descending coronary artery (LAD) at consecutive rates of 0.05, 0.5, and 5 ng/kg per minute did not affect NEMIF, LAD flow, left ventricular dP/dtmax, and arterial pressure despite large increments in coronary arterial and venous angiotensin II concentrations. In the presence of neuronal reuptake inhibition and {alpha}-adrenergic receptor blockade, left stellate ganglion stimulation increased NEMIF from 2.7±0.3 to 7.3±1.2 before, and from 2.3±0.4 to 6.9±1.3 nmol/L during, infusion of 0.5 ng/kg per minute angiotensin II. Sixty minutes of 70% LAD flow reduction caused a progressive increase in NEMIF from 0.9±0.1 to 16±6 nmol/L, which was not enhanced by concomitant infusion of 0.5 ng/kg per minute angiotensin II. In conclusion, we did not observe any facilitation of cardiac norepinephrine release by angiotensin II under basal conditions and during either physiological (ganglion stimulation) or pathophysiological (acute ischemia) sympathetic activation. Hence, angiotensin II is not a local mediator of cardiac sympathetic activity in the in vivo porcine heart.


Key Words: norepinephrine • angiotensin II • renin-angiotensin system • sympathetic nervous system




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Kawada, M. Mizuno, S. Shimizu, K. Uemura, A. Kamiya, and M. Sugimachi
Angiotensin II disproportionally attenuates dynamic vagal and sympathetic heart rate controls
Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1666 - H1674.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. J. Duncker and R. J. Bache
Regulation of Coronary Blood Flow During Exercise
Physiol Rev, July 1, 2008; 88(3): 1009 - 1086.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Kawada, T. Yamazaki, T. Akiyama, M. Li, C. Zheng, T. Shishido, H. Mori, and M. Sugimachi
Angiotensin II attenuates myocardial interstitial acetylcholine release in response to vagal stimulation
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2516 - H2522.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. Kawada, H. Kitagawa, T. Yamazaki, T. Akiyama, A. Kamiya, K. Uemura, H. Mori, and M. Sugimachi
Hypothermia reduces ischemia- and stimulation-induced myocardial interstitial norepinephrine and acetylcholine releases
J Appl Physiol, February 1, 2007; 102(2): 622 - 627.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Merkus, D. B. Haitsma, O. Sorop, F. Boomsma, V. J. de Beer, J. M. J. Lamers, P. D. Verdouw, and D. J. Duncker
Coronary vasoconstrictor influence of angiotensin II is reduced in remodeled myocardium after myocardial infarction
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2082 - H2089.
[Abstract] [Full Text] [PDF]